Bayer Stock

Bayer Net Income 2024

Bayer Net Income

5.11 B EUR

Ticker

BAYN.DE

ISIN

DE000BAY0017

WKN

BAY001

In 2024, Bayer's profit amounted to 5.11 B EUR, a -273.6% increase from the -2.94 B EUR profit recorded in the previous year.

The Bayer Net Income history

YEARNET INCOME (undefined EUR)
2029e6.23
2028e6.19
2027e5.89
2026e5.54
2025e5.33
2024e5.11
2023-2.94
20224.15
20211
2020-10.5
20194.09
20181.7
20177.34
20164.53
20154.11
20143.43
20133.19
20122.45
20112.47
20101.3
20091.36
20081.72
20074.71
20061.68
20051.6
20040.6

Bayer Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Bayer, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bayer from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bayer’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Bayer. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Bayer’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Bayer’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bayer’s growth potential.

Bayer Revenue, EBIT and net profit per share

DateBayer RevenueBayer EBITBayer Net Income
2029e52.65 B undefined0 undefined6.23 B undefined
2028e52.13 B undefined7.33 B undefined6.19 B undefined
2027e50.47 B undefined6.74 B undefined5.89 B undefined
2026e49.31 B undefined6.75 B undefined5.54 B undefined
2025e48.62 B undefined6.22 B undefined5.33 B undefined
2024e47.88 B undefined5.86 B undefined5.11 B undefined
202347.64 B undefined8.42 B undefined-2.94 B undefined
202250.74 B undefined7.98 B undefined4.15 B undefined
202144.08 B undefined6.88 B undefined1 B undefined
202041.4 B undefined-878 M undefined-10.5 B undefined
201943.55 B undefined4.66 B undefined4.09 B undefined
201836.74 B undefined-150 M undefined1.7 B undefined
201735.02 B undefined5.99 B undefined7.34 B undefined
201634.94 B undefined5.84 B undefined4.53 B undefined
201546.09 B undefined6.64 B undefined4.11 B undefined
201441.34 B undefined5.55 B undefined3.43 B undefined
201340.16 B undefined4.97 B undefined3.19 B undefined
201239.76 B undefined3.91 B undefined2.45 B undefined
201136.53 B undefined3.97 B undefined2.47 B undefined
201035.09 B undefined2.89 B undefined1.3 B undefined
200931.17 B undefined3.77 B undefined1.36 B undefined
200832.92 B undefined3.87 B undefined1.72 B undefined
200732.39 B undefined3.84 B undefined4.71 B undefined
200628.96 B undefined2.76 B undefined1.68 B undefined
200527.38 B undefined2.81 B undefined1.6 B undefined
200429.76 B undefined1.81 B undefined603 M undefined

Bayer stock margins

The Bayer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bayer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bayer.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Bayer's sales revenue. A higher gross margin percentage indicates that the Bayer retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Bayer's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Bayer's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bayer's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bayer. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bayer's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Bayer Margin History

Bayer Gross marginBayer Profit marginBayer EBIT marginBayer Profit margin
2029e58.54 %0 %11.83 %
2028e58.54 %14.06 %11.88 %
2027e58.54 %13.36 %11.67 %
2026e58.54 %13.68 %11.24 %
2025e58.54 %12.79 %10.97 %
2024e58.54 %12.23 %10.66 %
202358.54 %17.68 %-6.17 %
202260.84 %15.73 %8.18 %
202161.85 %15.61 %2.27 %
202053.77 %-2.12 %-25.35 %
201959.55 %10.7 %9.39 %
201858.14 %-0.41 %4.61 %
201767.49 %17.12 %20.95 %
201666.36 %16.7 %12.97 %
201554.35 %14.41 %8.92 %
201451.84 %13.42 %8.29 %
201351.82 %12.39 %7.94 %
201252.06 %9.84 %6.15 %
201150.79 %10.86 %6.76 %
201051.26 %8.23 %3.71 %
200951.44 %12.1 %4.36 %
200850.01 %11.77 %5.22 %
200749.51 %11.84 %14.55 %
200647.25 %9.54 %5.81 %
200545.12 %10.27 %5.83 %
200441.59 %6.08 %2.03 %

Bayer Aktienanalyse

What does Bayer do?

Bayer AG is a German company that was founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal. The company started out as a manufacturer of dyes, but over time it has evolved into a leading global agrochemical, health, and life science company. Bayer's business model is based on the goal of finding innovative solutions to the societal challenges of the future. This includes promoting agriculture and health, as well as sustainability and the preservation of natural resources. Bayer specializes in three business areas: Pharmaceuticals, Consumer Health, and Crop Science. In the Pharmaceuticals division, Bayer develops and markets innovative drugs for a variety of diseases. The company focuses on research and development in key therapy areas such as cardiology, oncology, hematology, neurology, and immunology. Well-known and successful brands from Bayer in the Pharmaceuticals sector include Xarelto, Kogenate, Stivarga, Eylea, and Nexavar. In the Consumer Health division, Bayer develops and distributes products for consumer health and well-being. This includes self-medication products, dietary supplements, contact lens care products, and animal health products. Well-known brands from Bayer Consumer Health include Aspirin, Bepanthen, Berocca, Coppertone, and Advantage. In the Crop Science division, Bayer develops and markets products and solutions for agriculture. This includes crop protection products, seeds, plant breeding, and digital farming. The goal is to help farmers worldwide operate sustainably and productively to meet the growing demand for food. Well-known brands from Bayer Crop Science include Roundup, Decis, Diflubenzuron, and Dekalb. Bayer is known for its innovative power and has made many inventions and discoveries throughout its history. It was one of the first companies to develop synthetic dyes, and in 1897, it was also the first company in Germany to manufacture Aspirin. Since then, Bayer has made numerous groundbreaking discoveries and is now at the forefront of the pharmaceutical and agrochemical industry. Bayer is headquartered in Leverkusen and operates in over 90 countries worldwide. The company employs over 100,000 people and had a turnover of around 41 billion euros in 2020. The company is also committed to reducing its ecological footprint in line with its business goals and strives to improve sustainability in its value chain. Bayer ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Bayer revenue by segment

  • 41 % Pharmaceuticals

  • 13 % Consumer Health

  • 1 % All Other Segments

  • 45 % Crop Science

Net Income Details

Understanding Bayer's Profit Margins

The profit margins of Bayer represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Bayer's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Bayer's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Bayer's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Bayer’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Bayer stock

How much profit has Bayer made this year?

Bayer has made 5.11 B EUR this year.

How has the profit developed compared to last year?

The profit has increased by -273.6% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Bayer publish its earnings?

Bayer publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Bayer?

The profits of Bayer are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Bayer?

You can learn more about the earnings of Bayer by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Bayer pay?

Over the past 12 months, Bayer paid a dividend of 2.4 EUR . This corresponds to a dividend yield of about 12.31 %. For the coming 12 months, Bayer is expected to pay a dividend of 2.43 EUR.

What is the dividend yield of Bayer?

The current dividend yield of Bayer is 12.31 %.

When does Bayer pay dividends?

Bayer pays a quarterly dividend. This is distributed in the months of May, June, June, May.

How secure is the dividend of Bayer?

Bayer paid dividends every year for the past 26 years.

What is the dividend of Bayer?

For the upcoming 12 months, dividends amounting to 2.43 EUR are expected. This corresponds to a dividend yield of 12.45 %.

In which sector is Bayer located?

Bayer is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bayer kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bayer from 5/2/2024 amounting to 0.11 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Bayer pay the last dividend?

The last dividend was paid out on 5/2/2024.

What was the dividend of Bayer in the year 2023?

In the year 2023, Bayer distributed 2 EUR as dividends.

In which currency does Bayer pay out the dividend?

The dividends of Bayer are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bayer stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Bayer

Our stock analysis for Bayer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bayer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.